<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="14927">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01869608</url>
  </required_header>
  <id_info>
    <org_study_id>13-005</org_study_id>
    <nct_id>NCT01869608</nct_id>
  </id_info>
  <brief_title>Postpartum Screening of Type 2 Diabetes</brief_title>
  <acronym>Tot ou tard</acronym>
  <official_title>Can we Screen Type 2 Diabetes on the 2nd Day After Delivery in Women Who Had Gestational Diabetes Mellitus?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Lawson Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <authority>Canada: Ethics Review Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gestational diabetes mellitus (GDM) complicates 5 to 30 % of pregnancies. GDM is defined as
      hyperglycemia with onset or first recognition during pregnancy. Because it is a forerunner
      of type 2 diabetes mellitus (T2DM), professional associations recommend T2DM postpartum
      screening (T2DM-pPS) at 6 weeks/6 months post delivery, using a 75g oral glucose tolerance
      test (OGTT).

      However, less than a quarter of these women are screened. This recommendation has failed for
      multiple reasons; the most important being that busy new mothers must deal with the major
      inconveniences of returning to a sampling center for a 2h testing session, bringing baby
      along or paying for a sitter, transportation, parking… A mother-friendly solution is direly
      needed.

      The investigators hypothesize that, in these women, results of an OGTT performed after
      delivery on the last day of their hospital stay (OGTT-1) will predict results of the
      recommended OGTT (OGTT-2) at 6 weeks/6 months postpartum.

      The main aim of our project is to determine the optimal cut-off value for the 2h glucose
      result during OGTT-1 in order to predict abnormal glucose tolerance status at OGTT-2 (the
      gold standard), in the same woman.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Diagnosis of abnormal glucose tolerance</measure>
    <time_frame>12 weeks postpartum</time_frame>
    <safety_issue>No</safety_issue>
    <description>Oral glucose tolerance test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient's satisfaction</measure>
    <time_frame>12 weeks post-partum</time_frame>
    <safety_issue>No</safety_issue>
    <description>Satisfaction questionnaire</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">145</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>postpartum screening</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral glucose tolerance test 2 days post-partum</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>oral glucose tolerance test 2 days post-partum</intervention_name>
    <description>Screening for type 2 diabetes after gestational diabetes mellitus.</description>
    <arm_group_label>postpartum screening</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women aged between 18 and 45 years;

          -  Having a positive diagnosis of gestational diabetes mellitus (IADPSG criteria);

          -  Treated with diet or insulin;

          -  Have given birth to a child at term; gestational age &gt; 37 weeks;

          -  Have been followed during her pregnancy by a physician who delivers in CHUS;

          -  Have signed the consent form.

        Exclusion Criteria:

          -  History of glucose intolerance or diabetes before the pregnancy;

          -  Have presented another obstetrical pathology during the pregnancy;

               -  Severe gestational high blood pressure with proteinuria;

               -  Delayed intrauterine development syndrome;

               -  Pregnancy with more than a foetus;

               -  Drug addiction;

               -  Had complications during the delivery such as:

          -  Moderate to severe postpartum bleeding;

          -  Surgery in postpartum (curettage, hysterectomy, etc.).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Luc Ardilouze, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Research Center Étienne-Le Bel of the Sherbrooke University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Luc Ardilouze, MD, PhD</last_name>
    <phone>819-346-1110</phone>
    <phone_ext>15241</phone_ext>
    <email>Jean-Luc.Ardilouze@USherbrooke.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julie Ménard, PhD</last_name>
    <phone>819-346-1110</phone>
    <phone_ext>13534</phone_ext>
    <email>jumenard.chus@ssss.gouv.qc.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinical Research Center Étienne-Le Bel of the Sherbrooke University Hospital</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Luc Ardilouze, MD, PhD</last_name>
      <phone>819-346-1110</phone>
      <phone_ext>15241</phone_ext>
      <email>Jean-Luc.Ardilouze@USherbrooke.ca</email>
    </contact>
    <contact_backup>
      <last_name>Julie Ménard, PhD</last_name>
      <phone>819-346-1110</phone>
      <phone_ext>13534</phone_ext>
      <email>jumenard.chus@ssss.gouv.qc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Jean-Luc Ardilouze, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 4, 2014</lastchanged_date>
  <firstreceived_date>May 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Université de Sherbrooke</investigator_affiliation>
    <investigator_full_name>Jean-Luc Ardilouze</investigator_full_name>
    <investigator_title>Full professor, endocrinologist, researcher</investigator_title>
  </responsible_party>
  <keyword>postpartum screening</keyword>
  <keyword>type 2 diabetes</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
